Focused on medicines for rare diseases and autoimmune conditions, the company develops and markets specialty therapies including treatments for thyroid eye disease and chronic gout. Its portfolio is built around high-priced biologics and niche indications that generate outsized revenue from relative...
Market Cap: $26.6B52W Range: $116.30 – $116.34
This page tracks all publicly disclosed congressional trades in Horizon Therapeutics Public Limited Company (HZNP), a company in the Healthcare sector. 3 members of Congress have disclosed trades in this stock, including 4 purchases and 3 sales. All data is sourced from STOCK Act Periodic Transaction Reports filed with the House and Senate disclosure offices.